
In a recent pre-publication release in the "Cornea" journal, tear osmolarity showed both treatment response and evidence of lower variability compared with other commonly used signs of Dry Eye Disease (DED). The study included DED patients being treated over a 3 month period utilizing topical cyclosporine 0.05% (Restasis). By … [Read more...]




